Coupled Plasma Filtration Adsorption as a Potential Therapy for Critically III Covid-۱۹ Patients

  • سال انتشار: 1401
  • محل انتشار: مجله علوم دارویی و شیمی، دوره: 5، شماره: 2
  • کد COI اختصاصی: JR_JMCH-5-2_007
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 306
دانلود فایل این مقاله

نویسندگان

Jonny Jonny

Division of Nephrology, Internal Medicine Department, Presidential Central Army Hospital, Jakarta, Indonesia

Laurencia Violetta

Division of Nephrology, Internal Medicine Department, Presidential Central Army Hospital, Jakarta, Indonesia

چکیده

The Corona-۱۹ virus disease (Covid-۱۹) continues to cause an increasing number of deaths, mainly due to acute respiratory disorders. The high pandemic mortality and morbidity prompted clinicians to seek suitable adjunctive therapeutic methods to eliminate high cytokine levels effectively. This study aimed to review the combined plasma filtration adsorption (CPFA) technology and its potential efficacy in treating critically ill Covid-۱۹. CPFA combines plasma separation, adsorption, and hemofiltration techniques that meet the need to remove substances such as cytokines. Findings from the report suggest an immune dysregulation known as cytokine storm syndrome plays a role in severe and critically ill Covid-۱۹ patients. Extracorporeal blood purification targets cytokine elimination and is preferred as a bridging strategy to improve survival. Combined adsorption plasma filtration (CPFA) can remove various substances, including cytokines, without depleting physiologically essential proteins. CPFA can be considered and assessed in clinical trials to treat critically ill Covid-۱۹ patients. Paired Plasma Filtration Adsorption (PPFA) can be viewed as a potentially effective therapy in treating Covid-۱۹ patients in critical condition.

کلیدواژه ها

COVID-۱۹, Cytokine Storm, extracorporeal therapy, hemofiltration, plasma exchange

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.